Ryan Govender
Chief Executive Officer chez TREATT PLC
Fortune : 719 $ au 31/03/2024
Profil
Ryan Govender is currently the Chief Executive Officer, Secretary & Director at Treatt Plc.
He previously worked as the Chief Financial Officer at SPI Pharma, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/06/2023 | 973 ( 0,00% ) | 574 $ | 31/03/2024 | |
TREATT PLC
0,00% | 14/03/2024 | 27 ( 0,00% ) | 145 $ | 31/03/2024 |
Postes actifs de Ryan Govender
| Sociétés | Poste | Début |
|---|---|---|
| TREATT PLC | Chief Executive Officer | 01/01/2024 |
Anciens postes connus de Ryan Govender
| Sociétés | Poste | Fin |
|---|---|---|
SPI Pharma, Inc.
 SPI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of The Garfield Weston Foundation, SPI Pharma, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Scott Thomson. | Director of Finance/CFO | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TREATT PLC | Process Industries |
| Entreprise privées | 1 |
|---|---|
SPI Pharma, Inc.
SPI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of The Garfield Weston Foundation, SPI Pharma, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Scott Thomson. | Health Technology |
